Somatic APC Inactivation Mechanisms in Sporadic Colorectal Cancer Cases in Hungary
The role of germline inactivation of the adenomatosis polyposis coli (APC) gene in hereditary colorectal cancer is well known, being the most important cause of familial adenomatosus polyposis (FAP) syndrome. Hereditary cases with germline mutations, however, account only for 5–10% of colorectal can...
Gespeichert in:
Veröffentlicht in: | Pathology oncology research 2008-03, Vol.14 (1), p.51-56 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 56 |
---|---|
container_issue | 1 |
container_start_page | 51 |
container_title | Pathology oncology research |
container_volume | 14 |
creator | Kámory, Enikő Olasz, Judit Csuka, Orsolya |
description | The role of germline inactivation of the adenomatosis polyposis coli (APC) gene in hereditary colorectal cancer is well known, being the most important cause of familial adenomatosus polyposis (FAP) syndrome. Hereditary cases with germline mutations, however, account only for 5–10% of colorectal cancers. The somatic inactivation of this gene has also been observed in sporadic cases. In order to examine the inactivation mechanisms of the APC gene we screened 70 sporadic colorectal cancer cases (27 rectal, 43 intestinal) of different stages for promoter hypermethylation, allelic imbalance (AI) and somatic mutations. The presence of promoter hypermethylation was observed in 21 cases (30%). Fifteen of the examined tumors (21%) showed AI, and also 15 tumors (21%) carried at least one somatic mutation. Thirteen of the detected alterations were novel variations: seven frameshifts, four missense mutations and two polymorphisms. Biallelic inactivation was found in 15 patients (21%). These results suggest that the inactivation of the APC gene is very common in sporadic colorectal cancer, and the main inactivation mechanism of the APC gene is promoter hypermethylation. Allelic imbalance has the same frequency as mutations, and mutations in the APC gene are more common in the early stages and in tumors located in the rectum. |
doi_str_mv | 10.1007/s12253-008-9019-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71615349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2794413691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-b8fd42a42d0cb94e8effd532d63827af5a5e5ac079491c3ba41160d9485f22373</originalsourceid><addsrcrecordid>eNp1kF1LwzAUhoMoTqc_wBspCN5V89UmuRxF3WCiOL0OWZrOjjaZSSvs35vZgSJ4dfLxnDcnDwAXCN4gCNltQBhnJIWQpwIikW4PwAnKCE4xh-wwrnE8pCLLR-A0hDWMPbnIj8EIcZILRuEJeFm4VnW1TibPRTKzSnf1Z9w7mzwa_a5sHdqQ1DZZbJxXZeQK1zhvdKeapFBWGx9LMN_MtLcr5bdn4KhSTTDn-zoGb_d3r8U0nT89zIrJPNWEwS5d8qqkWFFcQr0U1HBTVWUcvswJx0xVmcpMpjRkggqkyVJRhHJYCsqzCmPCyBhcD7kb7z56EzrZ1kGbplHWuD5IhvIog4oIXv0B1673Ns4mEUKEc0b4jkIDpb0LwZtKbnzdxv9IBOVOtxx0y6hb7nTLbey53Cf3y9aUPx17vxHAAxDilV0Z_-vpf1O_AHcbifQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1113887389</pqid></control><display><type>article</type><title>Somatic APC Inactivation Mechanisms in Sporadic Colorectal Cancer Cases in Hungary</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Kámory, Enikő ; Olasz, Judit ; Csuka, Orsolya</creator><creatorcontrib>Kámory, Enikő ; Olasz, Judit ; Csuka, Orsolya</creatorcontrib><description>The role of germline inactivation of the adenomatosis polyposis coli (APC) gene in hereditary colorectal cancer is well known, being the most important cause of familial adenomatosus polyposis (FAP) syndrome. Hereditary cases with germline mutations, however, account only for 5–10% of colorectal cancers. The somatic inactivation of this gene has also been observed in sporadic cases. In order to examine the inactivation mechanisms of the APC gene we screened 70 sporadic colorectal cancer cases (27 rectal, 43 intestinal) of different stages for promoter hypermethylation, allelic imbalance (AI) and somatic mutations. The presence of promoter hypermethylation was observed in 21 cases (30%). Fifteen of the examined tumors (21%) showed AI, and also 15 tumors (21%) carried at least one somatic mutation. Thirteen of the detected alterations were novel variations: seven frameshifts, four missense mutations and two polymorphisms. Biallelic inactivation was found in 15 patients (21%). These results suggest that the inactivation of the APC gene is very common in sporadic colorectal cancer, and the main inactivation mechanism of the APC gene is promoter hypermethylation. Allelic imbalance has the same frequency as mutations, and mutations in the APC gene are more common in the early stages and in tumors located in the rectum.</description><identifier>ISSN: 1219-4956</identifier><identifier>EISSN: 1532-2807</identifier><identifier>DOI: 10.1007/s12253-008-9019-y</identifier><identifier>PMID: 18369740</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Allelic Imbalance ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Colorectal cancer ; Colorectal Neoplasms - genetics ; DNA Methylation ; Female ; Gene Silencing ; Genes, APC ; Humans ; Hungary ; Immunology ; Male ; Middle Aged ; Mutation ; Oncology ; Original Paper ; Pathology ; Polymerase Chain Reaction ; Promoter Regions, Genetic ; Tumors ; Vegetables</subject><ispartof>Pathology oncology research, 2008-03, Vol.14 (1), p.51-56</ispartof><rights>Arányi Lajos Foundation 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-b8fd42a42d0cb94e8effd532d63827af5a5e5ac079491c3ba41160d9485f22373</citedby><cites>FETCH-LOGICAL-c370t-b8fd42a42d0cb94e8effd532d63827af5a5e5ac079491c3ba41160d9485f22373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12253-008-9019-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12253-008-9019-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18369740$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kámory, Enikő</creatorcontrib><creatorcontrib>Olasz, Judit</creatorcontrib><creatorcontrib>Csuka, Orsolya</creatorcontrib><title>Somatic APC Inactivation Mechanisms in Sporadic Colorectal Cancer Cases in Hungary</title><title>Pathology oncology research</title><addtitle>Pathol. Oncol. Res</addtitle><addtitle>Pathol Oncol Res</addtitle><description>The role of germline inactivation of the adenomatosis polyposis coli (APC) gene in hereditary colorectal cancer is well known, being the most important cause of familial adenomatosus polyposis (FAP) syndrome. Hereditary cases with germline mutations, however, account only for 5–10% of colorectal cancers. The somatic inactivation of this gene has also been observed in sporadic cases. In order to examine the inactivation mechanisms of the APC gene we screened 70 sporadic colorectal cancer cases (27 rectal, 43 intestinal) of different stages for promoter hypermethylation, allelic imbalance (AI) and somatic mutations. The presence of promoter hypermethylation was observed in 21 cases (30%). Fifteen of the examined tumors (21%) showed AI, and also 15 tumors (21%) carried at least one somatic mutation. Thirteen of the detected alterations were novel variations: seven frameshifts, four missense mutations and two polymorphisms. Biallelic inactivation was found in 15 patients (21%). These results suggest that the inactivation of the APC gene is very common in sporadic colorectal cancer, and the main inactivation mechanism of the APC gene is promoter hypermethylation. Allelic imbalance has the same frequency as mutations, and mutations in the APC gene are more common in the early stages and in tumors located in the rectum.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Allelic Imbalance</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Colorectal cancer</subject><subject>Colorectal Neoplasms - genetics</subject><subject>DNA Methylation</subject><subject>Female</subject><subject>Gene Silencing</subject><subject>Genes, APC</subject><subject>Humans</subject><subject>Hungary</subject><subject>Immunology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Oncology</subject><subject>Original Paper</subject><subject>Pathology</subject><subject>Polymerase Chain Reaction</subject><subject>Promoter Regions, Genetic</subject><subject>Tumors</subject><subject>Vegetables</subject><issn>1219-4956</issn><issn>1532-2807</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kF1LwzAUhoMoTqc_wBspCN5V89UmuRxF3WCiOL0OWZrOjjaZSSvs35vZgSJ4dfLxnDcnDwAXCN4gCNltQBhnJIWQpwIikW4PwAnKCE4xh-wwrnE8pCLLR-A0hDWMPbnIj8EIcZILRuEJeFm4VnW1TibPRTKzSnf1Z9w7mzwa_a5sHdqQ1DZZbJxXZeQK1zhvdKeapFBWGx9LMN_MtLcr5bdn4KhSTTDn-zoGb_d3r8U0nT89zIrJPNWEwS5d8qqkWFFcQr0U1HBTVWUcvswJx0xVmcpMpjRkggqkyVJRhHJYCsqzCmPCyBhcD7kb7z56EzrZ1kGbplHWuD5IhvIog4oIXv0B1673Ns4mEUKEc0b4jkIDpb0LwZtKbnzdxv9IBOVOtxx0y6hb7nTLbey53Cf3y9aUPx17vxHAAxDilV0Z_-vpf1O_AHcbifQ</recordid><startdate>20080301</startdate><enddate>20080301</enddate><creator>Kámory, Enikő</creator><creator>Olasz, Judit</creator><creator>Csuka, Orsolya</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20080301</creationdate><title>Somatic APC Inactivation Mechanisms in Sporadic Colorectal Cancer Cases in Hungary</title><author>Kámory, Enikő ; Olasz, Judit ; Csuka, Orsolya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-b8fd42a42d0cb94e8effd532d63827af5a5e5ac079491c3ba41160d9485f22373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Allelic Imbalance</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Colorectal cancer</topic><topic>Colorectal Neoplasms - genetics</topic><topic>DNA Methylation</topic><topic>Female</topic><topic>Gene Silencing</topic><topic>Genes, APC</topic><topic>Humans</topic><topic>Hungary</topic><topic>Immunology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Oncology</topic><topic>Original Paper</topic><topic>Pathology</topic><topic>Polymerase Chain Reaction</topic><topic>Promoter Regions, Genetic</topic><topic>Tumors</topic><topic>Vegetables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kámory, Enikő</creatorcontrib><creatorcontrib>Olasz, Judit</creatorcontrib><creatorcontrib>Csuka, Orsolya</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pathology oncology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kámory, Enikő</au><au>Olasz, Judit</au><au>Csuka, Orsolya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Somatic APC Inactivation Mechanisms in Sporadic Colorectal Cancer Cases in Hungary</atitle><jtitle>Pathology oncology research</jtitle><stitle>Pathol. Oncol. Res</stitle><addtitle>Pathol Oncol Res</addtitle><date>2008-03-01</date><risdate>2008</risdate><volume>14</volume><issue>1</issue><spage>51</spage><epage>56</epage><pages>51-56</pages><issn>1219-4956</issn><eissn>1532-2807</eissn><abstract>The role of germline inactivation of the adenomatosis polyposis coli (APC) gene in hereditary colorectal cancer is well known, being the most important cause of familial adenomatosus polyposis (FAP) syndrome. Hereditary cases with germline mutations, however, account only for 5–10% of colorectal cancers. The somatic inactivation of this gene has also been observed in sporadic cases. In order to examine the inactivation mechanisms of the APC gene we screened 70 sporadic colorectal cancer cases (27 rectal, 43 intestinal) of different stages for promoter hypermethylation, allelic imbalance (AI) and somatic mutations. The presence of promoter hypermethylation was observed in 21 cases (30%). Fifteen of the examined tumors (21%) showed AI, and also 15 tumors (21%) carried at least one somatic mutation. Thirteen of the detected alterations were novel variations: seven frameshifts, four missense mutations and two polymorphisms. Biallelic inactivation was found in 15 patients (21%). These results suggest that the inactivation of the APC gene is very common in sporadic colorectal cancer, and the main inactivation mechanism of the APC gene is promoter hypermethylation. Allelic imbalance has the same frequency as mutations, and mutations in the APC gene are more common in the early stages and in tumors located in the rectum.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>18369740</pmid><doi>10.1007/s12253-008-9019-y</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1219-4956 |
ispartof | Pathology oncology research, 2008-03, Vol.14 (1), p.51-56 |
issn | 1219-4956 1532-2807 |
language | eng |
recordid | cdi_proquest_miscellaneous_71615349 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Adult Aged Aged, 80 and over Allelic Imbalance Biomedical and Life Sciences Biomedicine Cancer Research Colorectal cancer Colorectal Neoplasms - genetics DNA Methylation Female Gene Silencing Genes, APC Humans Hungary Immunology Male Middle Aged Mutation Oncology Original Paper Pathology Polymerase Chain Reaction Promoter Regions, Genetic Tumors Vegetables |
title | Somatic APC Inactivation Mechanisms in Sporadic Colorectal Cancer Cases in Hungary |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T19%3A02%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Somatic%20APC%20Inactivation%20Mechanisms%20in%20Sporadic%20Colorectal%20Cancer%20Cases%20in%20Hungary&rft.jtitle=Pathology%20oncology%20research&rft.au=K%C3%A1mory,%20Enik%C5%91&rft.date=2008-03-01&rft.volume=14&rft.issue=1&rft.spage=51&rft.epage=56&rft.pages=51-56&rft.issn=1219-4956&rft.eissn=1532-2807&rft_id=info:doi/10.1007/s12253-008-9019-y&rft_dat=%3Cproquest_cross%3E2794413691%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1113887389&rft_id=info:pmid/18369740&rfr_iscdi=true |